Clinical Trials in Austin

Showing 6541-6560 of 15,205 trials

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

NCT05722262

The goal of this clinical trial is to demonstrate the bioequivalence of single oral administration of K-001 relative to single oral co-administration of separate tablets of K-877-ER and CSG452 in healthy adult volunteers, and to characterize the food effect on the Pharmacokinetics(PK) of K-001.

Healthy

Kowa Research Institute, Inc.30 participantsStarted Feb 2023

Austin, Texas, United States

COMPLETEDPhase 1< 1 mile

Oral AMXT 1501 Dicaprate in Combination With DFMO

NCT03536728

A Phase 1 study will be conducted to establish safety and dose level of AMXT 1501 dicaprate alone, and in combination with DFMO, in cancer patients.

CancerSolid TumorSolid Carcinoma+1 more

Aminex Therapeutics, Inc.56 participantsStarted Jun 2018

Austin, Texas, United States • Houston, Texas, United States • San Antonio, Texas, United States +1 more locations

TERMINATEDPhase 3< 1 mile

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

NCT02245568

The purpose of this study is to provide subjects who have completed participation in a Phase 2 or Phase 3 trial of LMTM continued access to therapy and to evaluate the long-term safety of LMTM.

Alzheimer's DiseaseBehavioral Variant Frontotemporal Dementia

TauRx Therapeutics Ltd913 participantsStarted Aug 2014

Phoenix, Arizona, United States • Fountain Valley, California, United States • Laguna Hills, California, United States +132 more locations

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Oral AMXT 1501 Dicaprate in Combination With DFMO

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Find Trials by Condition in Austin

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Study of Diroximel Fumarate in the Real-World Setting

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Dimethyl Fumarate (DMF) Observational Study

Impact of Prevnar 13 on Ear Infections in Children

Evaluation of Preoperative N1539 in Total Knee Arthroplasty

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Proof of Concept Study of Binocular Videogames Versus Patching for Amblyopia

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer